January 23, 2019
A Pennsylvania federal judge has dismissed Pharmaceutical Manufacturing Research Services Inc.'s suit against the FDA over its approval of Inspirion Delivery Sciences LLC's abuse-deterrent opioid, RoxyBond, finding PMRS doesn't have standing because it doesn't currently have a competing drug.